glp-1 anti-obesity The drug market may prove smaller than expected In recent years, GLP-1 medications

The Bridge is a real change for this patient

Contribution statement This manuscript reports studies performed over 15 years and that have involved generations of students and postdoctoral fellows

Semaglutide was recently approved as a treatment for the prevention of heart attacks, and preliminary studies suggest that tirzepatide also imparts broad cardiovascular benefits

Ozempic is a brand-name, FDA-approved formulation of semaglutide, most commonly used for type 2 diabetes and, more recently, for weight management

This transporter is positively associated with the secretion of incretin hormones, which enhance glucose uptake in the intestine